Pulmonary Hypertension

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA safety_alert · 2016-06-24
Adempas not for use in patients with pulmonary hypertension caused by idiopathic interstitial pneumonia
The EMA guidance states that Adempas (riociguat) should not be used in patients with pulmonary hypertension due to idiopathic interstitial p…